Top compounds associated with response to NRTN


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.007
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.1 0.007
mRNA LY317615 GDSC1000 pan-cancer AAC -0.094 0.007
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.095 0.007
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC 0.081 0.007
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.008
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.097 0.008
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.008
mRNA PI-103 GDSC1000 pan-cancer AAC 0.083 0.008
mRNA AZ-3146 CTRPv2 pan-cancer AAC 0.092 0.008
Download CSV